Toxic Shock Syndrome
Below are links to information related to toxic shock syndrome (TSS). Click on the right menu or scroll down to view general information and programs, research, statistics and guidelines on this topic.
sordellii Toxic Shock Syndrome after Medical Abortion with Mifepristone
and Intravaginal Misoprostol- United States and Canada, 2001-2005 (7/30/05)
The Food and Drug Administration, CDC, and local and state health departments continue to investigate the cases of four women in the United States who died after medical abortions during 2003-2005 with Mifeprex┬« (mifepristone, formerly RU-486) and intravaginal misoprostol. A fifth death after medical abortion with the same drugs was reported in 2001, in Canada. Three of the deaths have been linked to infection with Clostridium sordellii.
Methicillin-resistant Staphylococcus aureus Toxic Shock Syndrome (3/30/05)
This is a report of a case of toxic shock syndrome (TSS) due to a methicillin-resistant S. aureus strain that produced a TSS toxin 1. A 54-year-old woman was admitted to the emergency ward of Brugmann University Hospital, Brussels, with a 2-day history of myalgia, diarrhea, and vomiting. She had undergone surgery for a palate neoplasia 2 months earlier, and again 2 weeks earlier, in another hospital. After the second operation, she had been treated for a local scar infection with amoxicillin-clavulanic acid for 1 week. TSS caused by MRSA strains has been found extensively in Japan, rarely in the United States, and, thus far, not in Europe.
Early and Definitive
Diagnosis of Toxic Shock Syndrome by Detection of Marked Expansion of T-Cell-Receptor
Vβ2-Positive T Cells
Two cases are reported of Toxic Shock Syndrome (TSS) with puerperal infection that could be diagnosed at the early stage of the clinical course by detecting a marked expansion of T-cell-receptor V 2-positive T cells, as measured by flow cytometric analysis. The symptoms of one patient were too complex to permit diagnosis according to the clinical criteria without evaluation of the TSST-1-reactive T cells. The role of T-cell analysis in peripheral blood mononuclear cells in the diagnosis of TSS is discussed. From the Emerging Infectious Diseases journal.
Syndrome in the United States: 1979-1996
Menstrual toxic shock syndrome (TSS) emerged as a public health threat to women of reproductive age in 1979-80. Surveillance data was reviewed for the period 1979 to 1996, when 5,296 cases were reported, and changes in the epidemiologic features of TSS were discussed in this article.
- Alcohol Use
- Birth Defects and Disabilities
- Bleeding Disorders
- Bone Health
- Chronic Fatigue Syndrome (CFS)
- Community Health
- Deaths, Leading Causes
- Emergency Preparedness and Response
- Environmental Health
- Falls and Fractures
- Flu (Influenza)
- Foodborne Illness
- General Health
- Group B Strep
- Health Care
- Heart Disease and Stroke (Cardiovascular Disease)
- Immunizations and Vaccines
- Infectious Diseases
- Mental Health
- Occupational Health (Workplace Safety and Health)
- Oral Health
- Overweight and Obesity
- Physical Activity
- Pregnancy and Reproductive Health
- Sexually Transmitted Sexually Transmitted Infections (STIs and HIV/AIDS)
- Smoking and Tobacco
- Toxic Shock Syndrome
- Travelers' Health
- Workplace Safety and Health (Occupational Health)
This site contains documents in PDF format. You will need Adobe Acrobat Reader to access the file. If you do not have the Acrobat Reader, you may download a free copy from the Adobe Web site.
Page last modified: March 27, 2013
Page last reviewed: March 27, 2013